CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-22 | Robb Gary Charles Chief Business Officer | Shares withheld for taxes | −2,674 | $71.17 | $190K | 13,364 |
| 2025-08-22 | Robb Gary Charles Chief Business Officer | Option exercise · Stock option (right to buy) | −5,000 | 145,000 | ||
| 2025-08-11 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $14.08 | $31K | 2,200 |
| 2025-08-11 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $72.30 | $159K | 0 |
| 2025-08-11 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 5,500 | ||
| 2025-08-08 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +35,007 | $21.65 | $758K | 40,494 |
| 2025-08-08 | Guyer William Chief Development Officer | Sale 10b5-1 | −35,007 | $71.77 | $2.5M | 5,487 |
| 2025-08-08 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −35,007 | 350,000 | ||
| 2025-08-05 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +14 | $21.65 | $303 | 5,501 |
| 2025-08-05 | Guyer William Chief Development Officer | Sale 10b5-1 | −14 | $71.77 | $1K | 5,487 |
| 2025-08-05 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −14 | 385,007 | ||
| 2025-08-01 | Maduck Sean See Remarks | Option exercise 10b5-1 | +35,007 | $5.05 | $177K | 42,688 |
| 2025-08-01 | Maduck Sean See Remarks | Sale 10b5-1 | −27,865 | $67.53 | $1.9M | 14,823 |
| 2025-08-01 | Maduck Sean See Remarks | Sale 10b5-1 | −5,428 | $68.52 | $372K | 9,395 |
| 2025-08-01 | Maduck Sean See Remarks | Sale 10b5-1 | −1,714 | $69.70 | $119K | 7,681 |
| 2025-08-01 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −35,007 | 21,986 | ||
| 2025-08-01 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −16,745 | $67.81 | $1.1M | 2,884,625 |
| 2025-08-01 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −17,809 | $68.87 | $1.2M | 2,866,816 |
| 2025-08-01 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −5,446 | $69.65 | $379K | 2,861,370 |
| 2025-08-01 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +5,823 | $13.56 | $79K | 15,889 |
Page 21 of 61 · 1,220 trades